WO2008098056A3 - Chélate à haute relaxation high relaxivity chelates - Google Patents
Chélate à haute relaxation high relaxivity chelates Download PDFInfo
- Publication number
- WO2008098056A3 WO2008098056A3 PCT/US2008/053186 US2008053186W WO2008098056A3 WO 2008098056 A3 WO2008098056 A3 WO 2008098056A3 US 2008053186 W US2008053186 W US 2008053186W WO 2008098056 A3 WO2008098056 A3 WO 2008098056A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chelates
- high relaxivity
- relaxivity
- chelating ligands
- metal
- Prior art date
Links
- 239000002184 metal Substances 0.000 abstract 3
- 239000003446 ligand Substances 0.000 abstract 2
- 239000013522 chelant Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
- C07F9/2404—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/242—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of hydroxyaryl compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La présente invention concerne des ligands chélateurs de métal, et plus particulièrement des ligands chélateurs de métal ayant une haute relaxation lorsqu'ils se trouvent sous une forme de chélate de métal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67190507A | 2007-02-06 | 2007-02-06 | |
US11/671,905 | 2007-02-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008098056A2 WO2008098056A2 (fr) | 2008-08-14 |
WO2008098056A3 true WO2008098056A3 (fr) | 2008-10-30 |
Family
ID=39592734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/053186 WO2008098056A2 (fr) | 2007-02-06 | 2008-02-06 | Chélate à haute relaxation high relaxivity chelates |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008098056A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008134289A2 (fr) * | 2007-04-26 | 2008-11-06 | Mallinckrodt Inc. | Complexes de lanthanide insaturés de manière coordonnée à relaxivité élevée |
DE102008045937B4 (de) * | 2008-04-11 | 2017-01-26 | Johannes-Gutenberg-Universität Mainz | Radiopharmakon aus einem Metallion und einem Markierungsvorläufer und Verwendung des Radiopharmakons |
CN102272101A (zh) * | 2008-12-05 | 2011-12-07 | 分子制药洞察公司 | 用于癌症治疗和成像的ca-ix特异性放射性药物 |
MX2012009817A (es) * | 2010-02-25 | 2012-09-12 | Indian Inst Of Chemical Technology | Sintesis de magnolol y sus compuestos analogos. |
US8722020B2 (en) * | 2010-03-31 | 2014-05-13 | General Electric Company | Hydroxylated contrast enhancement agents |
JP2015007054A (ja) * | 2014-07-24 | 2015-01-15 | コルゲート・パーモリブ・カンパニーColgate−Palmolive Company | マグノロールおよびその類似体化合物の合成 |
CN106316745A (zh) * | 2016-08-24 | 2017-01-11 | 苏州氟拓化工科技有限公司 | 一种联苯化合物的制备方法 |
WO2019087626A1 (fr) * | 2017-10-31 | 2019-05-09 | 東洋合成工業株式会社 | Générateur de photo-acide, composition de résine et procédé de production d'un dispositif à l'aide de ladite composition de résine |
-
2008
- 2008-02-06 WO PCT/US2008/053186 patent/WO2008098056A2/fr active Application Filing
Non-Patent Citations (2)
Title |
---|
CARAVAN P ET AL: "Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications", CHEMICAL REVIEWS, vol. 99, 20 August 1999 (1999-08-20), pages 2293 - 2352, XP002375825, ISSN: 0009-2665 * |
ZECH S G ET AL: "Probing the water coordination of protein-targeted MRI contrast agents by pulsed ENDOR spectroscopy.", CHEMPHYSCHEM : A EUROPEAN JOURNAL OF CHEMICAL PHYSICS AND PHYSICAL CHEMISTRY, vol. 6, no. 12, 9 December 2005 (2005-12-09), pages 2570 - 2577, XP009105424, ISSN: 1439-4235 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008098056A2 (fr) | 2008-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008098056A3 (fr) | Chélate à haute relaxation high relaxivity chelates | |
HRP20120872T1 (en) | Heteromolecular metal-humic (chelate) complexes | |
WO2009077443A3 (fr) | Azolylméthyloxiranes, leur utilisation et agents les contenant | |
WO2010125189A3 (fr) | Procédé de préparation d'un substrat métallisé, ledit substrat et ses utilisations | |
WO2009077500A3 (fr) | Azolylméthyloxiranes, leur utilisation et agents les contenant | |
GB0607494D0 (en) | Metal complexes | |
GB0601143D0 (en) | Uses, methods and compositions | |
ZA200903489B (en) | Compositions and methods for treating a neoplasm | |
WO2010015657A3 (fr) | Nouveaux alcoxypyrazoles | |
WO2009021779A3 (fr) | Préparation de liant polyester à modification minérale, procédés pour sa fabrication, et utilisation de cette préparation | |
GB0815325D0 (en) | Metal complex,polymeric compound,and element comprising these | |
EP2336377A4 (fr) | Alliage de fer, élément d alliage de fer et procédé de fabrication associé | |
PL2225314T3 (pl) | Samoprzywierające silikony, sposób ich wytwarzania, stosujące je kompleksy i zastosowanie | |
FI20070677A0 (fi) | Kelaatteja, kelatoivia yhdisteitä ja niistä johdettuja konjugaatteja | |
EP1865659A4 (fr) | Procede d implementation d un compte partage prepaye | |
EP2209588A4 (fr) | Procédé de production d'une aube, cette aube et composant de stator comprenant l'aube | |
WO2009137605A3 (fr) | Variants de crig à maturation d'affinité | |
EP1979437A4 (fr) | Complexes organometalliques | |
WO2008022033A3 (fr) | Procédés de prévention ou de traitement d'une maladie cardiovasculaire | |
HK1141526A1 (en) | Metal chelates having a perfluorinated peg group, method for the production thereof, and use thereof | |
MY152884A (en) | (s)-(-)-amlodipine camsylate or hydrate thereof and pharmaceutical composition comprising same | |
WO2011070160A3 (fr) | Procédé de liaison complexe d'ions métalliques | |
WO2009093059A3 (fr) | Composés destinés à être utilisés en tant que ligands | |
WO2010056472A3 (fr) | Compositions et méthodes d'utilisation de variants de thrombomoduline | |
WO2009115083A3 (fr) | Composant rf et procédé de traitement de surface dudit composant rf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08729170 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08729170 Country of ref document: EP Kind code of ref document: A2 |